Sunscreen Innovation Act
Latest action · Jul 29, 2014 Received in the Senate.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 13, 2014
- Passed HouseJul 28, 2014
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
(This measure has not been amended since it was reported to the House on July 24, 2014. The summary of that version is repeated here.)
Sunscreen Innovation Act - (Sec. 2) Amends the Federal Food, Drug, and Cosmetic Act to establish a process for the review and approval of over-the-counter (OTC) sunscreen active ingredients.
Allows any person to request that the Secretary of Health and Human Services (HHS) determine whether an OTC sunscreen active ingredient or combination of ingredients is safe and effective.
Requires the Secretary to review any request regarding a sunscreen active ingredient or combination of ingredients that has been in use and that is not included in the stayed sunscreen monograph published by the Food and Drug Administration (FDA).
Directs the Secretary to invite the sponsor of the request to provide data and other information on the safety and efficacy of the sunscreen active ingredient or combination of ingredients. Requires the Secretary to determine whether the provided information is sufficient to conduct a review, and if so, file the request, and if not, explain to the sponsor why the provided information is insufficient.
Requires the Director of the Center for Drug Evaluation and Research to complete a review of a filed request and determine the safety and efficacy of the sunscreen active ingredient or combination of ingredients within 300 days for new requests or a shorter timeframe for requests pending before enactment of this Act. Directs the Commissioner of Food and Drugs to make the determination if the Director does not make a determination in the allowed timeframe.
Allows sunscreen active ingredients that are determined to be safe and effective to be used in OTC sunscreen products.
Directs the Comptroller General (GAO) to report on the progress of the Secretary in establishing this process and the role of the Commissioner of Food and Drugs in issuing determinations on pending requests. Requires the Secretary to report on the decisions made about the safety and efficacy of sunscreen active ingredients, the amount of time between submission and decision for each request, the cost of the review process, and recommended improvements to the review process.Cosponsors 34
Members who signed on, in the order they did. Signatures ran from Mar 13, 2014 to Jul 15, 2014; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MI | John D. Dingell | Original | Mar 13, 2014 |
| R-KY | Andy Barr | Mar 27, 2014 | |
| R-KY | Brett Guthrie | Mar 27, 2014 | |
| R-KY | Harold Rogers | Mar 27, 2014 | |
| R-OH | Patrick J. Tiberi | Mar 27, 2014 | |
| D-CA | Sam Farr | Mar 27, 2014 | |
| R-OH | Steve Stivers | Mar 27, 2014 | |
| R-VA | J. Randy Forbes | Apr 7, 2014 | |
| D-DE | John C. Carney, Jr. | Apr 7, 2014 | |
| R-NJ | Leonard Lance | Apr 7, 2014 | |
| R-NC | Renee L. Ellmers | Apr 7, 2014 | |
| D-NY | Carolyn B. Maloney | Apr 10, 2014 | |
| R-TN | Marsha Blackburn | Apr 10, 2014 | |
| R-AR | Tim Griffin | Apr 10, 2014 | |
| R-FL | Ander Crenshaw | Apr 29, 2014 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Mar 13, 2014Markup Jul 15, 2014Reported Jul 24, 2014 |
| Health Subcommittee | Referred Mar 14, 2014Markup Jun 19, 2014Reported Jun 19, 2014 |
Actions 16
Everything that happened, newest first.
- Jul 29, 2014Received in the Senate.
- Jul 28, 2014Mr. Whitfield moved to suspend the rules and pass the bill, as amended.
- Jul 28, 2014Considered under suspension of the rules. (consideration: CR H6928-6933)
- Jul 28, 2014DEBATE - The House proceeded with forty minutes of debate on H.R. 4250.
- Jul 28, 2014Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6928-6930)
- Jul 28, 2014Motion to reconsider laid on the table Agreed to without objection.
- Jul 24, 2014Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-558.
- Jul 24, 2014Placed on the Union Calendar, Calendar No. 418.
- Jul 15, 2014Committee Consideration and Mark-up Session Held.
- Jul 15, 2014Ordered to be Reported (Amended) by Voice Vote.
- Jul 14, 2014Committee Consideration and Mark-up Session Held.
- Jun 19, 2014Subcommittee Consideration and Mark-up Session Held.
- Jun 19, 2014Forwarded by Subcommittee to Full Committee (Amended) by Unanimous Consent .
- Mar 14, 2014Referred to the Subcommittee on Health.
- Mar 13, 2014Introduced in House
- Mar 13, 2014Referred to the House Committee on Energy and Commerce.
In the Congressional Record 2
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Extensions | Debate and remarks E1304 | Lois Frankel D-FL | Aug 1, 2014 |
| House | Debate and remarks H6928–H6933Text printed H6928–H6930 | Ed Whitfield R-KY, Fred Upton R-MI, John D. Dingell D-MI | Jul 28, 2014 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Committee report
Congressional Budget Office cost estimate
- Jul 24, 2014H.R. 4250, Sunscreen Innovation ActAs ordered reported by the House Committee on Energy and Commerce on July 15, 2014
Constitutional authority
The sponsor’s statement, as printed in the page H2434.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 113-137 | IMPROVING PREDICTABILITY AND TRANSPARENCY IN DEA AND FDA REGULATION221 pages | Energy and Commerce Committee | Apr 7, 2014 |
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46985 | FDA Regulation of Over-the-Counter (OTC) Drugs: Overview and Issues for Congress | Report | Dec 10, 2021 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 2141 | Sunscreen Innovation Act | Identical bill | Nov 26, 2014 |
Titles 4
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act to provide an alternative process for review of safety and effectiveness of nonprescription sunscreen active ingredients and for other purposes.
- Short Titles as Introduced
- Sunscreen Innovation Act
- Short Titles as Reported to House
- Sunscreen Innovation Act
- Short Titles as Passed House
- Sunscreen Innovation Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 4
Each version as it was printed, newest first.
- Jul 29, 2014Received in Senate
- Jul 28, 2014Engrossed in House
- Jul 24, 2014Reported in House
- Mar 13, 2014Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.